Mobarak S. Al-Shahrani

Director of the National Pharmacovigilance Center (NPC)
The Saudi Food and Drug Authority, Saudi Arabia

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Poster(s):

• (P-363) Assessing the Post Marketing Experience of Clopidogrel and Major Cardiovascular Events After PCI in Saudi Arabia Using the Saudi Food and Drug Authority (SFDA) Spontaneous Reporting System

• (P-364) The Establishment of Regional Pharmacovigilance (PV) Centers in Saudi Arabia

• (P-365) A Tenfold Increase in the Rate of Adverse Drug Event Reports in Saudi Arabia